These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30674868)

  • 1. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
    Yang Y; Chen D; Liu H; Yang K
    Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC9 promotes tumor progression in oral squamous cell carcinoma by regulating microRNA-545-3p/laminin subunit gamma 2.
    Ning B; Guo S; Mei Y
    Bioengineered; 2021 Dec; 12(1):7907-7919. PubMed ID: 34612783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GACAT1 targeting miRNA-149 regulates the molecular mechanism of proliferation, apoptosis and autophagy of oral squamous cell carcinoma cells.
    Chen J; Chen X; Fu L; Chen J; Chen Y; Liu F
    Aging (Albany NY); 2021 Aug; 13(16):20359-20371. PubMed ID: 34460438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway.
    Lu N; Jiang Q; Xu T; Gao Q; Wang Y; Huang Z; Huang Z; Xu X
    J Exp Clin Cancer Res; 2024 Sep; 43(1):267. PubMed ID: 39343925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
    Liu W; Yao Y; Shi L; Tang G; Wu L
    J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological clock gene PER1 affects the development of oral squamous cell carcinoma by altering the circadian rhythms of cell proliferation and apoptosis.
    Yin S; Zhang Z; Tang H; Yang K
    Chronobiol Int; 2022 Sep; 39(9):1206-1219. PubMed ID: 35678317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway.
    Remadevi V; Jaikumar VS; Vini R; Krishnendhu B; Azeez JM; Sundaram S; Sreeja S
    Phytomedicine; 2024 Jul; 130():155721. PubMed ID: 38788395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
    Li Z
    BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT/ERK
    Gao L; Dou ZC; Ren WH; Li SM; Liang X; Zhi KQ
    Cell Death Dis; 2019 Oct; 10(10):745. PubMed ID: 31582727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.